As the climate crisis focuses more attention on alternatives to fossil fuels, nuclear energy is gaining more popular support in the U.S. as one of those alternatives. . . . → Read More: Infographic – Nuclear Power Support Grows in U.S.
|
|||||
       |
 Comments are closed  New products, Regulations  economics, energy, physical sciences, physics, solar, statistics, wind 
The U.S. Food and Drug Administration issued new regulatory guidance for clinical trials of medical devices designed to prevent or treat opioid use disorder. . . . → Read More: FDA Issues Guidance for Opioid Therapy Device Trials Comments are closed Regulations biomedical, clinical trials, FDA, life sciences, medical device, psychiatric 
A biotechnology company creating living tissue from a person’s stem cells says it received FDA clearance for a clinical trial of its replacement knee cartilage. . . . → Read More: Trial Cleared for Lab-Grown Replacement Knee Cartilage Comments are closed New products, Regulations biomedical, biotechnology, chemistry, clinical trials, engineering, entrepreneurs, FDA, life sciences, pharmaceuticals, physical sciences, preclinical, stem cells, university 
A recent survey shows majorities of American adults would like technology companies or the government to restrict the spread of false information online. . . . → Read More: Infographic – Most in U.S. Favor False Online Info Limits 
A treatment for HIV taken just once, using the genome-editing technology Crispr, is receiving fast-track designation from the U.S. Food and Drug Administration. . . . → Read More: One-Time Crispr HIV Therapy Given Fast-Track Status Comments are closed New products, Regulations biomedical, biotechnology, chemistry, clinical trials, FDA, genomics, health care, HIV, licensing, life sciences, pharmaceuticals, physical sciences, university 
A recent survey shows a solid bipartisan majority of U.S. adults favors at least some government regulation of artificial intelligence, including people who say they use A.I. . . . → Read More: Infographic – U.S. Public Backs A.I. Regulation Comments are closed Regulations behavioral science, computer science, engineering, mathematics, physical sciences, statistics 
A review of insurance claims shows patients facing obstacles to coverage for their migraine therapies are also more likely to need emergency care for treatment. . . . → Read More: Insurance Barriers, Migraine Hospital Visits Linked Comments are closed Business conditions, Regulations biomedical, economics, health care, medical device, pharmaceuticals, statistics, university 
A study of insurance claims records matching the design of randomized clinical trials shows claims data can in some cases resemble clinical trial results to make causal inferences. . . . → Read More: Real World Evidence Shown to Emulate Some Clinical Trials Comments are closed New products, Regulations biomedical, clinical trials, computer science, economics, engineering, FDA, life sciences, mathematics, pharmaceuticals, physical sciences, software, university 
A biotechnology industry group calls Friday’s ruling in a Federal district court to suspend approval of the drug mifepristone “an assault on science.” . . . → Read More: Biotech Group Blasts Reproductive Drug Ruling Comments are closed Regulations biomedical, biotechnology, FDA, health care, life sciences, pharmaceuticals 
A developer of treatments for eye diseases says it received clearance from FDA to begin a clinical trial of a sustained-release implant therapy for glaucoma. . . . → Read More: Trial Okayed for Glaucoma Treatment Implant Comments are closed New products, Regulations biomedical, biotechnology, clinical trials, FDA, life sciences, pharmaceuticals |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts